Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.35 |
| ▸ | CES1 | P23141 | 3/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514989 | 0.98 | MEN1 (0.43) | TP53MEN1KMT2ACA1CA2 | |
| SCHEMBL8211594 | 0.98 | MEN1 (0.43) | TP53MEN1KMT2ACA1CA2 | |
| SCHEMBL2022954 | 0.92 | — | — | |
| SCHEMBL2016323 | 0.81 | — | — | |
| SCHEMBL7689565 | 0.77 | FAAH (0.37) | MEN1KMT2ACA1CA2PPARA | |
| SCHEMBL1678827 | 0.77 | FAAH (0.37) | MEN1KMT2ACA1CA2PPARA | |
| SCHEMBL5132999 | 0.76 | TP53 (0.38) | TP53MEN1KMT2ACA1CA2 | |
| SCHEMBL7691832 | 0.75 | FAAH (0.41) | MEN1KMT2ACA1CA2PPARA | |
| SCHEMBL1679668 | 0.75 | FAAH (0.41) | MEN1KMT2ACA1CA2PPARA | |
| SCHEMBL1268408 | 0.75 | CA2 (0.43) | MEN1KMT2ACA1CA2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0397697-B1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? | RHONE POULENC RORER INT (US) | 1996-08-28 | — | — | EP | claimed |
| EP-0513030-B1 | NEW CIS-PLATINUM COMPLEXES WITH CHELATING AMINES AND SULPHINYL CARBOXYLATES | BOEHRINGER MANNHEIM ITALIA (IT) | 1994-01-26 | — | — | EP | claimed |
| US-5275827-A | Cis-platinum complexes with chelating amines and sulphinyl carboxylates | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1994-01-04 | — | — | US | claimed |
| EP-0397697-A4 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? | — | 1991-07-03 | — | — | EP | claimed |
| US-5028615-A | Treatment of hypersensitivity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-07-02 | — | — | US | claimed |
| EP-0397697-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4?. | RORER INT OVERSEAS (US) | 1990-11-22 | — | — | EP | claimed |
| WO-1989004304-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | claimed |
| EP-0755052-B1 | Optical recording medium | MITSUI CHEMICALS INC (JP) | 1999-11-17 | — | — | EP | disclosed |
| EP-0755052-A2 | Optical recording medium | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-01-22 | — | — | EP | disclosed |
| EP-0397697-B1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? | RHONE POULENC RORER INT (US) | 1996-08-28 | — | — | EP | disclosed |
| EP-0513030-B1 | NEW CIS-PLATINUM COMPLEXES WITH CHELATING AMINES AND SULPHINYL CARBOXYLATES | BOEHRINGER MANNHEIM ITALIA (IT) | 1994-01-26 | — | — | EP | disclosed |
| US-5275827-A | Cis-platinum complexes with chelating amines and sulphinyl carboxylates | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1994-01-04 | — | — | US | disclosed |
| US-5166210-A | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0397697-A4 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? | — | 1991-07-03 | — | — | EP | disclosed |
| US-5028615-A | Treatment of hypersensitivity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-07-02 | — | — | US | disclosed |
| EP-0397697-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4?. | RORER INT OVERSEAS (US) | 1990-11-22 | — | — | EP | disclosed |
| WO-1989004304-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |
| EP-0056475-A2 | Pharmaceutical compositions | MERCK PATENT GmbH (DE) | 1982-07-28 | — | — | EP | disclosed |